可溶性TREM2反映了肝纤维化状态,并预测了肝脏手术后的术后肝脏功能障碍
Jonas Santol1,2,3, Dragana Rajcic4, Gregor Ortmayr5
1Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.
JHEP reports : innovation in hepatology
|March 24, 2025
概括
可溶性TREM2 (sTREM2) 可以检测早期的慢性肝病,并预测术后的肝衰竭. 较高的sTREM2水平表明晚期纤维化和肝脏手术后的生存率较差.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 可溶性TREM2 (sTREM2) 与慢性肝病 (CLD) 的发展和检测有关.
- 表达TREM2的巨细胞在CLD的发病过程中起作用.
研究的目的:
- 评估sTREM2作为早期CLD检测的标志物.
- 评估 sTREM2 对肝切除术后肝衰竭 (PHLF) 的预测价值.
主要方法:
- 在切除肝脏之前和之后,测量了108名患者的sTREM2血水平.
- sTREM2的表现与FIB-4,MELD,Child-Pugh和LiMAx分数进行了比较.
主要成果:
- 术前较高的sTREM2水平与晚期肝纤维化和PHLF相关.
- 与其他标志物相比,sTREM2对PHLF的预测准确度更高.
- 升高的sTREM2预测了不良结果,并降低了肝脏手术后的整体存活率.
结论:
- 循环中的sTREM2有效地检测到早期的CLD,无论手术适用情况如何.
- sTREM2监测可以提高早期的CLD检测,并改善肝脏手术后的结果.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


